DEFERASIROX MSN LABORATORIES 360mg film-coated tablets medication leaflet

V03AC03 • deferasirox • Various | All other therapeutic products | Iron chelating agents

Deferasirox is an iron chelator used for the treatment of chronic iron overload in patients with frequent blood transfusions, such as those with major thalassemia. It works by binding excess iron, facilitating its elimination through feces.

The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.

Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.

This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.